| | 26441-05-4 Basic information More.. |
| Product Name: | 15-KETO PROSTAGLANDIN E2 | | Synonyms: | (E)-7-[(1R,2S,3R)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid;11-Hydroxy-9,15-dioxo-[5Z,11α,13E]-prosta-5,13-dien-1-oic acid: 15-Dehydroprostaglandin E2;(5Z,11R,13E)-11-Hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid;(5Z,13E)-11α-Hydroxy-9,15-dioxo-5,13-prostadiene-1-oic acid;(5Z,13E)-9,15-Dioxo-11α-hydroxyprosta-5,13-diene-1-oic acid;15-KetoPGE2;15-Oxoprostaglandin E2;15-keto Prostaglandin E2 Lipid Maps MS Standard | | CAS: | 26441-05-4 | | MF: | C20H30O5 | | MW: | 350.45 | | EINECS: | | | Mol File: | 26441-05-4.mol |  |
Use
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH. In vivo, 15-keto PGE2 is essentially inactive. It has an attenuated affinity for the EP4 and EP2 receptors compared to PGE2 (Ki = 2,600-15,000 nM for the inhibition of PGE2 binding compared to a Kd = 1 nM for PGE2).[Cayman Chemical]
|
|
26441-05-4
Recommend Suppliers |
|